medigraphic.com
ISSN 1405-8871 (Print)

2025, Number 2

<< Back Next >>

Aten Fam 2025; 32 (2)

Osteoporosis—Causes, Risks, and Prevention

Zapata-Ortega RN, Gasca-García AG

Language: Spanish
References: 14
Page: 150-153
PDF size: 198.30 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Weber T, Osteoporosis. En Goldman L, SchaferAI, eds. Goldman-Cecil. Tratado de medicina interna. 26.ª ed. Barcelona: Elsevier; 2021. p 1601- 1609.

  2. CENETEC. Diagnóstico y tratamiento de osteoporosisen mujeres posmenopáusicas. Guía de Evidenciasy Recomendaciones: Guía ade Práctica Clí-OsteoporosisAten Fam. 2025;32(2):150-153. http://dx.doi.org/10.22201/fm.14058871p.2025.2.91032nica [Internet]. [Citado 2024 Nov 22]. Disponibleen: Disponible en: http://www.cenetec-difusion.com/CMGPC/GPC-IMSS-673-18/ER.pdf

  3. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E. Current Status of theDiagnosis and Management of Osteoporosis. Int JMol Sci. 2022;23(16):9465.

  4. Gaceta UNAM. La osteoporosis afecta a 10 millonesde mexicanos [[Internet]. [Citado 2024 Nov22]. Disponible en: Disponible en: https://www.gaceta.unam.mx/la-osteoporosis-afecta-a-10-millones-de-mexicanos/

  5. Gobierno de México. Osteoporosis [Internet].[Citado 2024 Nov 22]. Disponible en:Disponible en: https://www.gob.mx/salud/prensa/345-osteoporosis-afecta-una-de-cadatres-mujeres-y-uno-de-cada-cinco-hombres-mayores-de-50-anos-inr?idiom=es#:~:text=En%20M%C 3%A 9 xico%2 C%20 una%20 de % 20 cada, y % 20 tratar % 20 esta % 20 enfermedad %2 C% 20 puntualiz%C3%B3.

  6. Gregson CL, Armstrong DJ, Bowden J, Cooper C,Edwards J, Gittoes NJL, et al. UK clinical guidelinefor the prevention and treatment of osteoporosis.Arch Osteoporos. 2022;17(1):58.

  7. Tański W, Kosiorowska J, Szymańska-ChabowskaA. Osteoporosis - risk factors, pharmaceuticaland non-pharmaceutical treatment. Eur Rev MedPharmacol Sci. 2021;25 (9):3557-3566.

  8. Paccou J, Cortet B. Osteoporosis: generalidades,estrategia diagnóstica. Tratados EMC-Aparato Locomotor.2023;55(2):1-10.

  9. Anam AK, Insogna K. Update on OsteoporosisScreening and Management. Med Clin North Am.2021;105(6):1117-1134.

  10. Ratajczak AE, Zawada A, Rychter AM, DobrowolskaA, Krela-Kaźmierczak I. Milk and DairyProducts: Good or Bad for Human Bone? PracticalDietary Recommendations for the Preventionand Management of Osteoporosis. Nutrients.2021;13(4):1329.

  11. 11.Rizzoli R, Chevalley T. Nutrition and OsteoporosisPrevention. Curr Osteoporos Rep. 2024Dec;22(6):515-522.

  12. Coll PP, Phu S, Hajjar SH, Kirk B, Duque G, TaxelP. The prevention of osteoporosis and sarcopenia inolder adults. J Am Geriatr Soc. 2021;69(5):1388-

  13. 1398.13. Amin U, McPartland A, O'Sullivan M, Silke C.An overview of the management of osteoporosisin the aging female population. Womens Health(Lond). 2023;19:17455057231176655

  14. LeBoff MS, Greenspan SL, Insogna KL, LewieckiEM, Saag KG, Singer AJ, Siris ES. The clinician'sguide to prevention and treatment of osteoporosis.Osteoporos Int. 2022;33(10):2049-2102.




2020     |     www.medigraphic.com